Replies to post #60845 on Biotech Values

[The Borg]

Recothrom was only approved on January 17th and you are pronouncing it a failure based on February sales numbers! Hospital P&T committees meet what, once a quarter? And then there's the bovine thrombin inventory they need to use up. The sales people need to convert clients, etc. Unbelievable.

Also, Omrix's human thrombin was approved in late August and as far we know they haven't sold a vial yet. Give it til late 2008 before deciding if Recothrom is a success or not. At this point in time, we simply don't know.

[exwannabe]

"I think management will lower Recothrom's price..."

I doubt this would happen until they get a chance to see what the real sales are. Remeber, they have to wait for :

. inventory of bThrombin to run out
. any contract to expire (probably)
. the next meeting of the purchasing dudes (whatever hospitals call them).

Likely they havn't had much at all of this yet (if any), just samples. If the 6 month sales figure don't start to show a solid uptake then we can wonder.